
Synergies Between Our Vaccine Expertise on the Development and Manufacturing of Cell and Gene Products
By IDT BiologikaWhat defines a leading vaccine CDMO in the cell and gene therapy business? The production of viral vectors and the manufacturing of cell and gene therapeutics are closely interlinked processes that offer significant synergies.
Leveraging these synergies can enhance efficiency, reduce costs, and improve product safety ‒ ultimately delivering multiple benefits to customers.
To read more, please download this free white paper.
